The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 1: | Linia 1: | ||
Pagina dedicata companiei Bio Blast [[PHARMA|Pharma]] Ltd listata cu simbolul US.ORPN | Pagina dedicata companiei [[BIO|Bio]] Blast [[PHARMA|Pharma]] Ltd listata cu simbolul US.ORPN | ||
==Descriere companie== | ==Descriere companie== | ||
BioBlast Pharma (www.bioblastpharma.com) is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The Company is rapidly building a diverse portfolio of product candidates with the potential to address unmet medical needs for incurable diseases. The BioBlast platforms are based on a deep understanding of the disease-causing bi ological processes, and potentially offer solutions for several diseases that share the same biological pathology. BioBlast was founded in 2012 and is traded on the [[Nasdaq|NASDAQ]] under the symbol "ORPN". | BioBlast [[PHARMA|Pharma]] (www.bioblastpharma.com) is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The Company is rapidly building a diverse portfolio of product candidates with the potential to address unmet medical needs for incurable diseases. The BioBlast platforms are based on a deep understanding of the disease-causing bi ological processes, and potentially offer solutions for several diseases that share the same biological pathology. BioBlast was founded in 2012 and is traded on the [[Nasdaq|NASDAQ]] under the symbol "ORPN". | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||